Red Tortoise LLC’s Emergent Biosolutions EBS Stock Holding History

Red Tortoise LLC’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-653	Closed	-$1.57K	–	564
2023 Q4	$1.57K	Buy	+653	New	+$1.53K	﹤0.01%	500

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Red Tortoise LLC's EBS Position: Q1 2024 in Review

Red Tortoise LLC sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 653 shares — an estimated $1.57K sold.

Red Tortoise LLC first reported a position in EBS in Q4 2023 and held it in 1 quarter. The position peaked at $1.57K in Q4 2023. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

Red Tortoise LLC reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
Red Tortoise LLC sold 653 Emergent Biosolutions shares in Q1 2024, an estimated $1.57K.
Red Tortoise LLC first reported a position in Emergent Biosolutions in Q4 2023 and held it in 1 quarter.
Red Tortoise LLC's Emergent Biosolutions position peaked at $1.57K in Q4 2023.
122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on Red Tortoise LLC's 13F filing for Q1 2024, filed 19 Apr 2024.